Health Day Reporter
Monday, December 12, 2016 (HealthDay News)-A new study shows that the number of babies experiencing apiate withdrawal at birth is skyrocketing due to the prevalence of substance abuse by pregnant women in rural areas of the United States. It has become clear.
These small victims of the US opioid epidemic are born of reliance on heroin and powerful prescription analgesics such as oxycontin, bicodone, and percoset. And the researchers say the public health crisis is having a bigger impact on rural populations than on urban cousins.
Investigators found that between 2004 and 2013, infant opioid withdrawal rates increased by nearly 80% in rural communities compared to cities.
“The size of the difference between rural and urban areas was not expected,” said Dr. Nicole Villapiano of the University of Michigan, the lead author of the study. She belongs to the Institute for Healthcare Policy and Innovation.
This class of drugs, including morphine and fentanyl, is highly addictive. Also, if a woman takes opioids during pregnancy, the risk of addiction can extend to the foetation.
Infant opioid withdrawal symptoms (also known as neonatal withdrawal syndrome) can increase the risk of low birth weight and seizures, as well as breathing, diet, and sleep problems in the first few weeks of life.
Some studies suggest that affected children may develop attention deficit problems in the future, but long-term risks remain unclear, Virapiano points out. did.
According to the background material of this study, maternal opioid use and infant withdrawal rates increased five-fold between 2000 and 2012.
To investigate geographic differences, researchers analyzed discharge data collected by the US Department of Medical Research and Quality between 2004 and 2013.
During that time, the number of diagnoses with neonatal withdrawal syndrome surged from just over 1 per 1,000 live births to nearly 8 per 1,000 live births.
In urban areas, the rate more than doubled, a slight increase in comparison. From just under 2 per 1,000 births in urban areas to nearly 5 per 1,000 births.
In 2003, the researchers found that rural infants accounted for only 13% of all neonatal opioid withdrawal cases in the country, but that number rose 21% north after 10 years.
According to Virapiano, the study does not assess the root cause of the trend, but suggests some possible factors.
“We know that rural patients are poor, have a high incidence of chronic illness, and tend to suffer from smoking, drinking and drug addiction,” said Virapiano.
“This, coupled with poor access to health care, makes rural patients particularly vulnerable to poor health,” she said. She explained that many of these women do not have access to primary care physicians and specialists, especially those who specialize in mental health and substance use.
Mark Asbridge is an associate professor of community health and epidemiology at Dalhousie University in Halifax, Canada. He supported those points.
“It’s a combination of problems. One hypothesis is that the proportion of pain in the community is often related to the local labor market,” said Asbridge.
“Rural labor markets such as coal mines, logging and fisheries tend to produce more pain, which means that these drugs are these rural ones before we really understand the potential addiction of opiates. We have built a strong foothold in the area, “he explained.
To make matters worse, North American general practitioners lack expertise in pain, mental health, and addiction, he said. And these are the care providers that patients usually see, especially in rural areas, Asbridge added.
“More pain, lack of expertise, and more use. In the local community, it’s a perfect storm,” Asbridge said.
Researchers have stated that treatment of these at-risk babies and their mothers is essential.
Pregnant women with opioid use disorders may benefit from a combination of medications such as buprenorphine and addiction treatment programs, the study’s authors suggest.
The March of Dimes states that babies experiencing withdrawal symptoms are often given methadone or morphine to relieve cravings and discomfort.
Source: Nicole LG Villapiano, MD, M.Sc., Robert Wood Johnson Foundation Clinician, Institute of Internal Medicine / Pediatric Health Policy Innovation, University of Michigan, Ann Arbor; Dr. Mark Asbridge, Dalhousie University, Halifax, Canada, Community Health And an associate professor of the Faculty of Epidemiology. December 12, 2016, JAMA Pediatrics,online
Local hospitals see a surge in opioid-dependent babies
Source link Local hospitals see a surge in opioid-dependent babies